Interestingly, exposition of SU-DHL-8, SU-DHL-2 and HT (DLBCL cell lines) resistant to anti-CD79b ADC (Pola) leads to CD20 upregulation and enhances RTX sensitivity via CDC and ADCC [95]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.